Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Common Stock to be Issued	Additional Paid-in Capital	Accumulated Deficit	Total
Balance, at Dec. 31, 2020		$ 1,273	$ 5	$ 17,342,559	$ (16,761,512)	$ 582,325
Balance, (in Shares) at Dec. 31, 2020		12,727,820	52,782
Sale of common stock, net of offering costs		$ 40		1,592,932		1,592,972
Sale of common stock, net of offering costs (in Shares)		403,024	1,675
Common stock issued for common stock issuable		$ 5	$ (5)
Common stock issued for common stock issuable (in Shares)		51,018	(51,143)
Common stock issued for services		$ 21		469,979		470,000
Common stock issued for services (in Shares)		205,000
Net loss for the period					(996,771)	(996,771)
Balance at Mar. 31, 2021		$ 1,339		19,405,470	(17,758,283)	1,648,526
Balance (in Shares) at Mar. 31, 2021		13,386,862	3,314
Balance, at Dec. 31, 2021		$ 1,960		47,672,600	(27,590,546)	20,084,014
Balance, (in Shares) at Dec. 31, 2021		19,597,419	1,389
Accretion of stock based compensation in connection with stock option grants				822,583		822,583
Accretion of stock-based professional fees in connection with stock option grants and shares				202,275		202,275
Net loss for the period					(3,365,846)	(3,365,846)
Balance at Mar. 31, 2022		$ 1,960		$ 48,697,458	$ (30,956,392)	$ 17,743,026
Balance (in Shares) at Mar. 31, 2022		19,597,419	1,389